About the Authors
- Toby Leslie, Christopher J. M. Whitty, Mark Rowland
- Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
- Toby Leslie, Ismail Mayan, Nasir Mohammed
- HeathNet TPO, Peshawar, North West Frontier Province, Pakistan
- Marnie Briceño, Carol Hopkins Sibley
- Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America
- Eveline Klinkenberg
- HealthNet TPO, Amsterdam, The Netherlands
Other than the partial funding by GlaxoSmithKline of this investigator-initiated study, CJMW has received funding for investigator -initiated research from Pfizer. None of the other authors have conflicts of interest to declare.
ICMJE criteria for authorship read and met: TL MB IM NM EK CHS CJMW MR. Agree with the manuscript's results and conclusions: TL MB IM NM EK CHS CJMW MR. Designed the experiments/the study: TL IM EK CJMW MR. Analyzed the data: TL MB EK CHS CJMW MR. Collected data/did experiments for the study: TL MB IM NM CHS. Enrolled patients: NM. Wrote the first draft of the paper: TL. Contributed to the writing of the paper: TL MB IM EK CHS CJMW MR. Planned and executed molecular analysis, analyzed molecular data, and edited final draft: CHS.